Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02892422 · ClinicalTrials.gov registry record · Phase 3
Flexible-dose, Long-term Safety Study of Lu AF35700 in Adult Patients With Schizophrenia
A Phase 3 study, sponsored by H. Lundbeck A/S.
- Completed
- Registry status
- Phase 3
- Development phase
- 528
- Enrollment target
NCT02892422 is a Phase 3 study that has completed, run by H. Lundbeck A/S. The registered enrollment target is 528 participants.
The verdict
NCT02892422, a Phase 3 study, has completed, sponsored by H. Lundbeck A/S.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 528 participants
- Enrollment target
Study Summary
To evaluate the safety and tolerability of the long-term treatment with Lu AF35700.
Interventions
- DRUG Lu AF35700
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 528 participants |
| Start Date | 2016-08 |
| Est. Completion | 2019-10-10 |
| Phase | Phase 3 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02892422
The ClinicalTrials.gov registry entry for NCT02892422 describes a study currently listed as completed, categorized as Phase 3. The registered enrollment target is 528 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is H. Lundbeck A/S, which has 72 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Lu AF35700 is the first listed.
NCT02892422 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02892422 about?
NCT02892422 is a clinical study titled "Flexible-dose, Long-term Safety Study of Lu AF35700 in Adult Patients With Schizophrenia". To evaluate the safety and tolerability of the long-term treatment with Lu AF35700.
What is the current status of trial NCT02892422?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 528 participants. The study started on 2016-08. Estimated completion is 2019-10-10.
What interventions are being tested in trial NCT02892422?
The interventions under investigation include: Lu AF35700 (DRUG).
Who is sponsoring clinical trial NCT02892422?
This trial is sponsored by H. Lundbeck A/S, which has 72 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.